rifampin and Behcet-Syndrome

rifampin has been researched along with Behcet-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for rifampin and Behcet-Syndrome

ArticleYear
Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease.
    Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 3

    We present a case of Mycobacterium kansasii olecranon bursitis in a woman with known immunosuppression secondary to the treatment received for her Behçet's disease. We found only one other case report of olecranon bursitis caused by M. kansasii in the literature, which, unlike our case, presented in an immunocompetent adult following trauma. This case extends the range of opportunistic mycobacterial infections that are associated with anti-tumour necrosis factor therapy.

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antitubercular Agents; Behcet Syndrome; Bursitis; Elbow; Ethambutol; Female; Humans; Immunocompromised Host; Infliximab; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin

2009
[Behcet's disease: therapeutic results with rifampicin].
    Der Zahnarzt; Colloquium med. dent, 1985, Volume: 29, Issue:1

    Topics: Adult; Behcet Syndrome; Female; Humans; Male; Middle Aged; Rifampin

1985